![](https://www.precisionvaccinations.com/sites/default/files/styles/article_metadata/public/Novavax%20Logo%20on%20building.jpg)
Novavax Achieved $415 Million in Revenue During Second Quarter 2024
(Precision Vaccinations News)Novavax, Inc. today announced its financial results and operational highlights for the second quarter ended June 30, 2024. The Company confirmed it achieved total revenue of $415 million in the second quarter of 2024 and ended …